A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
A Prospective, Observational, Multi-center Study to Gather Real World Use Data on the Effectiveness, Safety, and Site-of-service of the Cerene Device
Channel Medsystems
300 participants
Jun 9, 2023
OBSERVATIONAL
Conditions
Summary
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
Eligibility
Inclusion Criteria5
- Scheduled for a Cerene treatment
- years of age and older
- Provided informed consent to participate in the registry
- English speaking
- Agrees to complete a survey at specified time points from baseline to 12 Months
Exclusion Criteria2
- Physician discretion
- Vulnerable populations
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Real world use of Cerene.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05922657